Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,870 public trials 2,109 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

NCT03739931

Conditions
Carcinoma, Carcinoma, Squamous Cell, Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, +13 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Providence St. John's Health Center Santa Monica, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 24 locations
View Trial Details
Completed

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

NCT03126110

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +82 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University - Siteman Cancer Center St Louis, Missouri, United States
View all 38 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

NCT02872714

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Arizona Oncology Associates (Wilmot) Tucson, Arizona, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Care Center San Francisco, California, United States
  • Rocky Mountain Cancer Centers Boulder, Colorado, United States
View all 96 locations
View Trial Details
Completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT05007106

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Alaska Womens Cancer Care ( Site 1016) Anchorage, Alaska, United States
  • City of Hope Comprehensive Cancer Center ( Site 1001) Duarte, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Me-Chao Family Comprehensive Cancer Cente Orange, California, United States
  • Karmanos Cancer Institute ( Site 1007) Detroit, Michigan, United States
View all 73 locations
View Trial Details
Completed

Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer

NCT02475213

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations
  • Mayo Clinic - AZ Scottsdale, Arizona, United States
  • Christiana Care Health Services, Inc. Newark, Delaware, United States
  • Mayo Clinic - FL Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 20 locations
View Trial Details
Completed

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

NCT06273852

Conditions
Breast Diseases, Breast Neoplasms, Carcinoma, +13 more
Locations
  • LSU Health Sciences Center Shreveport, Louisiana, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Sarah Cannon Research Institute Charleston, South Carolina, United States
View Trial Details
Completed

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma

NCT05678218

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +15 more
Locations
  • University Hospital of Ghent Ghent, Belgium
  • Maastricht UMC+ Maastricht, Limburg, Netherlands
  • Amsterdam University Medical Center Amsterdam, North Holland, Netherlands
  • University Medical Center Groningen Groningen, Provincie Groningen, Netherlands
View Trial Details

Related conditions